{"denoms":[{"counts":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"14"},{"groupId":"BG003","value":"11"},{"groupId":"BG004","value":"8"},{"groupId":"BG005","value":"7"},{"groupId":"BG006","value":"14"},{"groupId":"BG007","value":"14"},{"groupId":"BG008","value":"14"},{"groupId":"BG009","value":"106"}],"units":"Participants"}],"groups":[{"description":"nab-paclitaxel 120 mg/m\\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.","id":"BG000","title":"Phase 1: Nab-Paclitaxel 120 mg/m^2"},{"description":"nab-paclitaxel 150 mg/m\\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.","id":"BG001","title":"Phase 1: Nab-Paclitaxel 150 mg/m^2"},{"description":"nab-paclitaxel 180 mg/m\\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.","id":"BG002","title":"Phase 1: Nab-Paclitaxel 180 mg/m^2"},{"description":"nab-paclitaxel 210 mg/m\\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.","id":"BG003","title":"Phase 1: Nab-Paclitaxel 210 mg/m^2"},{"description":"nab-paclitaxel 240 mg/m\\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.","id":"BG004","title":"Phase 1: Nab-Paclitaxel 240 mg/m^2"},{"description":"nab-paclitaxel 270 mg/m\\^2 IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity to establish the RP2D.","id":"BG005","title":"Phase 1: Nab-Paclitaxel 270 mg/m^2"},{"description":"Participants with Ewing's sarcoma: nab-paclitaxel at the RP2D (240 mg/m\\^2 in participants weighing \\> 10 kg and 11.5 mg/kg in participants weighing ≤ 10 kg) IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity.","id":"BG006","title":"Phase 2: Ewing's Sarcoma"},{"description":"Participants with neuroblastoma: nab-paclitaxel at the RP2D (240 mg/m\\^2 in participants weighing \\> 10 kg and 11.5 mg/kg in participants weighing ≤ 10 kg) IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity.","id":"BG007","title":"Phase 2: Neuroblastoma"},{"description":"Participants with rhabdomyosarcoma: nab-paclitaxel at the RP2D (240 mg/m\\^2 in participants weighing \\> 10 kg and 11.5 mg/kg in participants weighing ≤ 10 kg) IV on Days 1, 8 and 15 of a 28-day cycle until disease progression, death, withdrawal of consent, or unacceptable toxicity.","id":"BG008","title":"Phase 2: Rhabdomyosarcoma"},{"description":"Total of all reporting groups","id":"BG009","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"3.32","value":"11.7"},{"groupId":"BG001","spread":"5.84","value":"12.1"},{"groupId":"BG002","spread":"4.64","value":"10.2"},{"groupId":"BG003","spread":"5.36","value":"10.2"},{"groupId":"BG004","spread":"4.63","value":"11.6"},{"groupId":"BG005","spread":"2.97","value":"12.1"},{"groupId":"BG006","spread":"4.63","value":"10.1"},{"groupId":"BG007","spread":"3.42","value":"7.1"},{"groupId":"BG008","spread":"6.42","value":"12.4"},{"groupId":"BG009","spread":"4.81","value":"10.7"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"7"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"3"},{"groupId":"BG006","value":"6"},{"groupId":"BG007","value":"5"},{"groupId":"BG008","value":"9"},{"groupId":"BG009","value":"53"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"7"},{"groupId":"BG005","value":"4"},{"groupId":"BG006","value":"8"},{"groupId":"BG007","value":"9"},{"groupId":"BG008","value":"5"},{"groupId":"BG009","value":"53"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"3"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"2"},{"groupId":"BG008","value":"5"},{"groupId":"BG009","value":"17"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"7"},{"groupId":"BG003","value":"10"},{"groupId":"BG004","value":"5"},{"groupId":"BG005","value":"5"},{"groupId":"BG006","value":"11"},{"groupId":"BG007","value":"8"},{"groupId":"BG008","value":"8"},{"groupId":"BG009","value":"65"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"2"},{"groupId":"BG006","value":"3"},{"groupId":"BG007","value":"4"},{"groupId":"BG008","value":"1"},{"groupId":"BG009","value":"24"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"9"},{"groupId":"BG004","value":"8"},{"groupId":"BG005","value":"5"},{"groupId":"BG006","value":"11"},{"groupId":"BG007","value":"11"},{"groupId":"BG008","value":"12"},{"groupId":"BG009","value":"84"}]}],"title":"White"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"1"},{"groupId":"BG006","value":"3"},{"groupId":"BG007","value":"3"},{"groupId":"BG008","value":"1"},{"groupId":"BG009","value":"18"}]}],"title":"Not Collected or Reported"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"1"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"3"}]}],"title":"Other, Not Specified"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"1"},{"groupId":"BG009","value":"1"}]}],"title":"Black or African American"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"14"},{"groupId":"BG003","value":"11"},{"groupId":"BG004","value":"8"},{"groupId":"BG005","value":"7"},{"groupId":"BG006","value":"14"},{"groupId":"BG007","value":"14"},{"groupId":"BG008","value":"14"},{"groupId":"BG009","value":"106"}]}],"title":"Any Prior Cancer Treatment"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"11"},{"groupId":"BG003","value":"7"},{"groupId":"BG004","value":"6"},{"groupId":"BG005","value":"6"},{"groupId":"BG006","value":"12"},{"groupId":"BG007","value":"10"},{"groupId":"BG008","value":"10"},{"groupId":"BG009","value":"75"}]}],"title":"Prior Radiation Therapy"},{"categories":[{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"9"},{"groupId":"BG004","value":"5"},{"groupId":"BG005","value":"7"},{"groupId":"BG006","value":"10"},{"groupId":"BG007","value":"11"},{"groupId":"BG008","value":"6"},{"groupId":"BG009","value":"78"}]}],"title":"Prior Cancer Surgeries"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"14"},{"groupId":"BG003","value":"11"},{"groupId":"BG004","value":"8"},{"groupId":"BG005","value":"7"},{"groupId":"BG006","value":"14"},{"groupId":"BG007","value":"14"},{"groupId":"BG008","value":"14"},{"groupId":"BG009","value":"106"}]}],"title":"Prior Systemic Anticancer Therapy"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"14"},{"groupId":"BG003","value":"11"},{"groupId":"BG004","value":"8"},{"groupId":"BG005","value":"7"},{"groupId":"BG006","value":"14"},{"groupId":"BG007","value":"14"},{"groupId":"BG008","value":"14"},{"groupId":"BG009","value":"106"}]}],"title":"Prior Systemic Anticancer Regimens"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"3"},{"groupId":"BG005","value":"2"},{"groupId":"BG006","value":"3"},{"groupId":"BG007","value":"10"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"27"}]}],"title":"Prior Stem Cell Transplants"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"3"},{"groupId":"BG004","value":"2"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"1"},{"groupId":"BG007","value":"6"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"15"}]}],"title":"Other Prior Anticancer Therapies"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Participants With Any Prior Cancer Treatment","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"1.815","value":"3.69"},{"groupId":"BG001","spread":"1.832","value":"3.25"},{"groupId":"BG002","spread":"1.946","value":"3.64"},{"groupId":"BG003","spread":"2.461","value":"3.64"},{"groupId":"BG004","spread":"1.309","value":"3.00"},{"groupId":"BG005","spread":"0.816","value":"3.00"},{"groupId":"BG006","spread":"0.519","value":"2.50"},{"groupId":"BG007","spread":"0.663","value":"2.14"},{"groupId":"BG008","spread":"0.579","value":"2.21"},{"groupId":"BG009","spread":"1.552","value":"2.99"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Number of Prior Systemic Anticancer Regimens Received","unitOfMeasure":"systemic anticancer regimens"}]}